Not applicableActive Not RecruitingNCT07092332What this trial is testingYoung Vulvodynia: Effect and Efficacy of Multimodal Treatment.Who this might be right forVulvodynia Region Örebro County 15
Testing effectiveness (Phase 2)UnknownNCT05124431What this trial is testingAnlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Fudan University 30
Post-approval studies (Phase 4)UnknownNCT05916781What this trial is testingEffectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus ErythematosusLupus Nephritis Chinese SLE Treatment And Research Group 220
Large-scale testing (Phase 3)Study completedNCT02403401What this trial is testingSafety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy WomenWho this might be right forContraception Bayer 1,471
Testing effectiveness (Phase 2)UnknownNCT04635956What this trial is testingCamrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine CarcinomasWho this might be right forChemotherapyAnti-pd-1 AntibodyCervical Neuroendocrine Carcinoma+4 more Lei Li 20
Not applicableEnded earlyNCT04881851What this trial is testingEffects of Inositol Alone or Associated With Alpha-lipoic Acid in Polycystic Ovary Syndrome TreatmentWho this might be right forPolycystic Ovary Syndrome Universita di Verona 76
Testing effectiveness (Phase 2)Ended earlyNCT05256381What this trial is testingSOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid TumorsWho this might be right forNon-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more SOTIO Biotech AG 166
Post-approval studies (Phase 4)UnknownNCT05580354What this trial is testingSafety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder CancerWho this might be right forNon-muscle-invasive Bladder Cancer Ruijin Hospital 42
Large-scale testing (Phase 3)Not Yet RecruitingNCT07692672What this trial is testingIntrauterine G-CSF Infusion for Thin EndometriumWho this might be right forThin EndometriumFemale Infertility Nanjing University 620
Testing effectiveness (Phase 2)Ended earlyNCT04267120What this trial is testingLenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)Who this might be right forRenal Cell Carcinoma Washington University School of Medicine 11
Testing effectiveness (Phase 2)Study completedNCT05557279What this trial is testingUrinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 WeeksWho this might be right forOveractive Bladder Loyola University 53
Early research (Phase 1)Looking for participantsNCT05969795What this trial is testingComparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase SupportWho this might be right forPregnancy RelatedInfertility, Female ART Fertility Clinics LLC 342
Early research (Phase 1)Study completedNCT05940402What this trial is testingEvaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal FunctionWho this might be right forRenal Impairment AbbVie 58
Early research (Phase 1)Study completedNCT02475772What this trial is testingA Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal CarcinomatosisWho this might be right forOvarian Cancer Clemens Tempfer 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02397083What this trial is testingLevonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial CancerWho this might be right forAtypical Endometrial HyperplasiaFIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid Adenocarcinoma M.D. Anderson Cancer Center 102
Early research (Phase 1)Study completedNCT04348175What this trial is testingEvaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal ImpairmentWho this might be right forRenal Insufficiency Rhythm Pharmaceuticals, Inc. 32
Early research (Phase 1)Study completedNCT00792857What this trial is testingComparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)Who this might be right forChronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more OPKO IP Holdings II, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT06437353What this trial is testingSurufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian CancerWho this might be right forOvarian Cancer Anhui Provincial Cancer Hospital 74
Testing effectiveness (Phase 2)UnknownNCT04194671What this trial is testingClinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney InjuryWho this might be right forAcute Kidney InjuryMesenchymal Stem Cells Chinese PLA General Hospital 80
Early research (Phase 1)Study completedNCT01120314What this trial is testingPharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal ImpairmentWho this might be right forRenal Impairment Sanofi 48